ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Use cancer mortality, not 5-year survival, to track progress against cancer, researchers say.

July 29, 2005

Intramural Review System Described

September 10, 1982

$20 Million In Construction Funds Approved

April 2, 1976

NCI Seeks Health Care Provider Groups To Form Cancer Control Research Network

September 12, 1997

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

NIH Updates Policy On Large Grants

May 10, 1996